Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexmedetomidine with music therapy for sufentanil dose in tracheal intubation
ChiCTR2400083861Phase 4Not yet recruiting
- Sponsor
- Fuyang Hospital of Anhui Medical University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine (3 arms), sponsored by Fuyang Hospital of Anhui Medical University. Primary endpoint: Median effective dose of sufentanil for tracheal intubation. Planned start May 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2400083861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083861.